Dongcheng Pharmaceutical: Legal Opinion of Beijing Zhonglun Law Firm on the 2024 Third Extraordinary General Meeting of Shareholders of Yantai Dongcheng Pharmaceutical Group Co., Ltd.
Dongcheng Pharmaceutical: Announcement of Resolutions of the 2024 Third Extraordinary General Meeting of Shareholders
Dongcheng Pharmaceutical: Announcement on subsidiary companies providing guarantees to their wholly-owned subsidiaries
Dongcheng Pharmaceutical: Dongcheng Pharmaceutical: Implementation Notice for the Distribution of Rights for the First Three Quarters of 2024
Dongcheng Pharmaceutical: Notice on Convening the Third Extraordinary General Meeting of Shareholders in 2024
Dongcheng Pharmaceutical: Announcement of Resolutions of the 7th Meeting of the 6th Board of Directors
Dongcheng Pharmaceutical: Announcement on the change of accounting firm
Dongcheng Pharmaceutical: Announcement of Resolutions of the Fifth Meeting of the Sixth Board of Supervisors
Dongcheng Pharmaceutical: Announcement on wholly-owned subsidiaries receiving government subsidies
Dongcheng Pharmaceutical: Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders
Dongcheng Pharmaceutical: Legal Opinion of Beijing Zhonglun Law Firm on the 2024 Second Extraordinary General Meeting of Shareholders of Yantai Dongcheng Pharmaceutical Group Co., Ltd.
Dongcheng Pharmaceutical: Announcement on wholly-owned subsidiaries receiving government subsidies
Dongcheng Pharmaceutical: Announcement on the subsidiary\'s product 177Lu-LNC1004 being developed to obtain FDA Fast Track qualification
Dongcheng Pharmaceutical: Notice on Convening the Second Extraordinary General Meeting of Shareholders in 2024
Dongcheng Pharmaceutical: Announcement of Supervisory Committee Resolutions
Dongcheng Pharmaceutical: Announcement of Board Resolutions
Dongcheng Pharmaceutical: Report for the third quarter of 2024
Dongcheng Pharmaceutical: Announcement of the profit distribution plan for the first three quarters of 2024
Dongcheng Pharmaceutical: Announcement on supplementary pledge of part of the controlling shareholder\'s share and cancellation of part of the actual controller\'s share pledge
Dongcheng Pharmaceutical: Announcement on progress in providing guarantees for subsidiaries and their subsidiaries
No Data